top of page
Lake

Drew Hertig MBA, CLP

I help life science organizations succeed

Drew Hertig Profile Picture_3_edited_edi

Global business development and corporate strategy experience in the biotechnology and pharmaceutical industries through Phase 2 clinical

​

POSITIONING THE ASSET OR BUSINESS

TECH ASSESSMENT

Step one is performing diligence on the technology or asset: assessing strengths, weaknesses, opportunities and threats. From intellectual property to market size and everything in between.

CUSTOMER DISCOVERY

Next is connecting with potential customers, including all stakeholders along the value chain. Can your product or process perform the job for a margin a customer (or payer) is willing to pay (or reimburse)?

CORPORATE STRATEGY

This includes the business plan to get your product or service to the customer, communicated in a way that stakeholders understand. Are you resourced enough to hit key milestones?

HELLO
MY NAME IS

Drew

BUILDING GREAT PRODUCTS AND COMPANIES

OPERATIONS

Mapping out processes to ensure efficient use of capital and other resources by optimizing organizational structure, critical paths items, inputs/outputs, equipment and infrastructure.

BUSINESS DEVELOPMENT

Generating awareness and creating interactions ("collisions") that will grow the business. The more channels utilized, the greater the customer access, and the better the partnering options.

LICENSING & SALES

Biotechnology products and services provide significant value to the right customer. Creating the right profile is the key to understanding perceived value to each customer to maximize ROI.

Testimonials

"I’ve worked with Drew for over two years in my role as Senior Research/Project Scientist at [a preclinical pharmaceutical company]. From the very beginning, I was impressed with Drew’s ability to understand advanced concepts and establish a business case around potential products and licensing opportunities. Not only did he excel in partnership discovery—bringing on board three key development programs—he rallied the broader team and put into place actionable steps to uncover each program’s commercial value. Likewise, he effectively communicated concepts to key stakeholders including MD and PhD collaborators. Furthermore, as a Sr. Scientist I worked closely with Drew to offer input on evaluating and prioritizing external and internal programs. He incorporated my input as well as input from other senior scientific members to develop standardized templates to continually improve our decision-making process."

-Eric S., Sr. Scientist, Preclinical Pharma

How Can I Help?

Send me a message!

Location:

San Diego, CA

Thanks for submitting!

Social:

  • linkedin
Contact
bottom of page